CV Events After COVID Vaccine, Septal Reduction in Obstructive HCM, Acute Pulmonary Embolism Guideline Comparison
In this week’s View, Dr. Eagle looks at cardiovascular events following COVID vaccination in adults. He then explores long-term outcomes after septal reduction therapies in obstructive hypertrophic cardiomyopathy (HCM). Finally, Dr. Eagle discusses clinical practice guideline recommendations for acute pulmonary embolism.
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, COVID-19 Hub, Noninvasive Imaging, Vascular Medicine, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Heart Failure and Cardiomyopathies, Prevention
Keywords: EaglesEyeView, COVID-19, COVID-19 Vaccines, Heart Disease Risk Factors, Ablation, Arrhythmias, Cardiac, Hypertrophic Cardiomyopathy, Anticoagulants, Diagnostic Imaging, Pulmonary Embolism
